Category: Latest News
-
Boeing Explores Plans for 737 MAX Replacement, WSJ Says
Boeing Co (NYSE:BA) is reportedly planning a new single-aisle aircraft to eventually replace the 737 MAX, aiming to recover market share lost to Airbus (EU:AIR), according to the Wall Street Journal on Monday, citing sources familiar with the matter. The report states that CEO Kelly Ortberg met earlier this year with Rolls-Royce Holdings PLC (LSE:RR.)…
-
Oil Slips on OPEC+ Supply Hike and Kurdish Export Resumption
Crude oil prices declined on Tuesday as investors weighed an anticipated increase in OPEC+ production alongside the resumption of oil exports from Iraq’s semi-autonomous Kurdistan region via Turkey, stoking concerns about a potential oversupply. November Brent crude futures, expiring on Tuesday, fell 28 cents, or 0.4%, to $67.69 a barrel by 06:30 GMT, while December…
-
Gold Climbs to Record Levels as U.S. Shutdown Risk Weighs on Markets
Gold prices surged to new record highs in Asian trading on Tuesday, extending a strong rally over the past week as investors weighed the risk of an impending U.S. government shutdown. Persistent expectations for additional Federal Reserve rate cuts also supported metals, although silver and platinum eased slightly after Monday’s sharp gains. Copper prices also…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Futures Slide as Shutdown Deadline Looms; Gold Surges
U.S. equity futures moved lower on Tuesday as investors focused on a tense standoff in Washington over federal funding, with a potential government shutdown just hours away. A meeting between Republican and Democratic leaders and President Donald Trump on Monday ended without resolution, amplifying uncertainty. The risk of a shutdown has helped push gold prices…
-
U.S. Stocks Move Mostly Higher Amid Tech Sector Strength
Stocks moved mostly higher during trading on Monday, adding to the gains posted during last Friday’s session. The major averages all moved to the upside on the day, although buying interest was somewhat subdued. The major averages finished the day in positive territory but off their early highs. The Nasdaq climbed 107.09 points or 0.5…
-
SPAC News From The Last Seven Days
The Last Week’s Deals BEST SPAC I Acquisition Corp. (NASDAQ:BSAA) has announced it is to acquire HDEducation, a Nepal-based provider of counseling for studies in the USA, Canada, UK, Australia, Finland, Japan, Denmark, and South Korea. The deal includes stock consideration of $300mm. No date was given for the closing. Deal Closings And Approvals Ares…
-
Terra Innovatum and Ameresco Partner to Deploy Micro-Modular Reactors
September 29, 2025 — Terra Innovatum (NASDAQ:GSRT), a developer of micro-modular nuclear reactors, has signed a memorandum of understanding with Ameresco, a clean energy solutions provider, to advance the rollout of its SOLO™ micro-modular reactor in the United States and global markets. The agreement, announced alongside GSR III Acquisition Corp. (NASDAQ:GSRT), sets out a framework…
-
Electronic Arts Set to Go Private in $55 Billion Deal Led by Saudi PIF and Silver Lake
Electronic Arts (NASDAQ:EA), the renowned video game developer behind franchises such as Battlefield and Madden NFL, is set to go private in a $55 billion transaction backed by Saudi Arabia’s Public Investment Fund (PIF), Silver Lake, and Jared Kushner’s Affinity Partners. Under the agreement, EA shareholders will receive $210 per share in cash, with PIF…
-
Carnival Shares Surge Following Record-Breaking Q3 Earnings
Carnival Corporation (NYSE:CCL) shares climbed 5% in premarket trading Monday after the cruise giant reported record third-quarter results that exceeded Wall Street expectations, driven by robust demand and higher onboard pricing. The company posted adjusted earnings of $1.43 per share for Q3, surpassing analyst forecasts of $1.32. Revenue reached a new high of $8.2 billion,…
-
Applied Therapeutics Shares Plunge Following FDA Meeting on CMT-SORD Treatment
Applied Therapeutics (NASDAQ:APLT) saw its stock dive 55% in premarket trading Monday after the company disclosed uncertainty around the regulatory pathway for govorestat, its therapy for Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD). The clinical-stage biopharmaceutical firm recently met with the U.S. Food and Drug Administration (FDA) to discuss a potential new drug application for govorestat. However,…